24730-88-9

Basic information

• Product Name: Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate
• Synonyms: Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate;1,4-Dioxaspiro[4.5]decane-8-carboxylic acid, 8-methyl-, ethyl ester
• CAS NO: 24730-88-9
• Molecular Formula: C₁₂H₂₀O₄
• Molecular Weight: 228.2848
• Mol File: 24730-88-9.mol
• Article Data: 30

Chemical Properties

• Boiling Point: 297.0±40.0 °C(Predicted)
• Appearance: /
• Density: 1.10±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate(24730-88-9)
• EPA Substance Registry System: Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate(24730-88-9)

Safety Data

• Hazardous Substances Data: 24730-88-9(Hazardous Substances Data)

Usage

General Description

Ethyl 8-methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate is a complex organic chemical compound with a spiro ring structure. It is commonly used in the pharmaceutical and fragrance industries as a building block for the synthesis of various pharmaceuticals and perfumes. Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate possesses unique properties that make it valuable for a wide range of applications, including its ability to act as a potential drug candidate for various diseases. Its spiro ring structure and carboxylate functional group contribute to its chemical and biological activities, making it an important molecule in drug discovery and development. Furthermore, its specific functional groups and stereochemistry offer potential for further derivatization and modification to create new compounds with enhanced properties.

Upstream product

• 1489-97-0 ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 
• 74-88-4 methyl iodide 

Downstream Products

• 147905-77-9 ethyl 1-methyl-4-oxo-1-cyclohexanecarboxylate 
• 4111-01-7 4-methyl-4-vinylcyclohexan-1-one 

Relevant articles and documents

Divergent Total Syntheses of Yaequinolone-Related Natural Products by Late-Stage C-H Olefination

Divergent total syntheses of 10 yaequinolone-related natural products have been achieved for the first time by late-stage C-H olefination of 3,4-dioxygenated 4-aryl-5-hydroxyquinolin-2(1H)-ones, core structures of this family of natural products. A robust synthetic methodology to construct the core structures has been established, and the C-H olefination reaction has been carried out with synthetically useful yields and high levels of site-selectivity under mild reaction conditions in the presence of a Pd/S,O-ligand catalyst.

ETHANEDIAMINE-HETEROCYCLE DERIVATIVES AS INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASES

The present invention relates to ethanediamine-heterocycle compounds that are able to act as inhibitors of PRMTs (protein arginine methyltransferases) for treating cancer and other diseases mediated by PRMTs.

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains, and methods of synthesis of these compounds.